iifl-logo

Mahavir Advanced Remedies Ltd Share Price

150.65
(-1.98%)
Jan 6, 2015|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Mahavir Advanced Remedies Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

150.65

Prev. Close

153.7

Turnover(Lac.)

6.03

Day's High

150.65

Day's Low

150.65

52 Week's High

0

52 Week's Low

0

Book Value

7.84

Face Value

10

Mkt Cap (₹ Cr.)

171.14

P/E

0

EPS

0.19

Divi. Yield

0

Mahavir Advanced Remedies Ltd Corporate Action

No Record Found

Mahavir Advanced Remedies Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Mahavir Advanced Remedies Ltd SHAREHOLDING SNAPSHOT

13 May, 2025|01:45 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.96%

Foreign: 0.00%

Indian: 0.96%

Non-Promoter- 99.03%

Institutions: 0.00%

Non-Institutions: 99.03%

Custodian: 0.00%

Share Price

Mahavir Advanced Remedies Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2014Mar-2013Mar-2012Mar-2011

Equity Capital

11.36

11.36

3.84

3.76

Preference Capital

0

0

0

0

Reserves

-2.57

-2.71

-3.19

-2.87

Net Worth

8.79

8.65

0.65

0.89

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2014Mar-2013Mar-2012Mar-2011

Revenue

0.1

0.13

0.2

0.24

yoy growth (%)

-24.66

-34.3

-13.52

Raw materials

0

0

0

0

As % of sales

0

0

0

0

Employee costs

-0.06

-0.06

-0.18

0

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2014Mar-2013Mar-2012Mar-2011

Profit before tax

0.13

-0.15

-0.31

-0.04

Depreciation

0

0

0

-0.03

Tax paid

0

0

0

0

Working capital

0.13

8

0.59

Other operating items

View Cash Flow
Y/e 31 MarMar-2014Mar-2013Mar-2012Mar-2011

Growth matrix (%)

Revenue growth

-24.66

-34.3

-13.52

Op profit growth

-50.8

-49.06

4,095.3

EBIT growth

-189.95

-51.71

571.94

Net profit growth

-189.95

-51.71

571.94

View Ratios

No Record Found

Mahavir Advanced Remedies Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,686.25

128.434,04,587.861,181.050.85,985.3398.33

Divis Laboratories Ltd

DIVISLAB

5,940.85

76.081,57,710.95940.52,297513.62

Cipla Ltd

CIPLA

1,512

26.241,22,115.231,438.150.864,134.87360.72

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,238

60.071,09,583.714850.862,330222.38

Mankind Pharma Ltd

MANKIND

2,497.8

53.291,03,053.87416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Mahavir Advanced Remedies Ltd

Management

Register Office

Registrar Office

Director

Mani Murugadoss Rao

Director

Shantilal Purohit

Director

Anitha Mahesh

Chairman & Managing Director

BVS Kotewara Rao

Additional Director

Sanjay Kr Choradia

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Incorporated in 1992, Indo American Advance Pharmaceuitcals (IAAPL) is promoted by V Koteswara Rao, B V S Kkoteswara Rao and T Ramakrishna.The company is now setting up a project for manufacturing variety of formulations -- tablets, capsules, liquids and ointments in allopathic and ayurvedic/siddha division in the field of antibiotics, antibacterials, analgesics, anti-pyretics, anti-inflammatory, etc, both as branded and generic products. To part-finance the above project, IAAPL came with a public issue of Rs 2.75 cr.
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.